- Recommendation ID
What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate in the induction of remission in mild-to-moderate ulcerative colitis unresponsive to aminosalicylates?
- Any explanatory notes
To find out why the committee made the research recommendation on immunomodulators for unresponsive ulcerative colitis see rationale and impact.
Source guidance details
- Comes from guidance
- Ulcerative colitis: management
- Date issued
- May 2019
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|